Filter
1085
Text search:
World
Health
Organization
WHO,
Stop
TB
Featured
117
302
Language
Document type
733
126
118
46
28
15
10
3
2
2
2
Countries / Regions
50
40
28
28
26
23
23
23
23
23
23
22
20
18
18
17
16
13
13
13
12
12
12
11
10
8
8
7
7
7
5
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
433
92
43
41
20
14
14
Toolboxes
358
127
36
23
20
19
18
17
17
13
12
11
10
9
9
8
6
5
4
3
2
2
1
1
The purpose of this handbook is to bring together in summarized form the issues, recommended strategies and political measures involved in addressing each of the components of the STOP TB Strategy.
...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO
...
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver remi
...
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrant
...
This document contains a series of desk reviews for the eight ENGAGE-TB priority countries supported by the Global Fund (DRC, Kenya, Indonesia, Mozambique, Myanmar, Nigeria, Pakistan and Tanzania). The document provides a situation assessment and ga
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB
...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World
...
